SOUTH PLAINFIELD, N.J., Jan. 22, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
IMS Health: Pharma Should Make Better Use of Social Media To Engage Patients and Improve the Use of Medicines
Sanford Heisler Adds Four New Class Representatives To $250M Gender Discrimination Class Action Suit Against Pharma Giant Merck
Amended Complaint Includes More Evidence of Discrimination and Hostile Environment
NEWARK, N.J., Jan.
European Commission Grants Marketing Authorization for Gilead's Sovaldi® (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection
SANFORD HEISLER ADDS FOUR NEW CLASS REPRESENTATIVES TO $250M GENDER DISCRIMINATION CLASS ACTION SUIT AGAINST PHARMA GIANT MERCK
Acceptance of NDA for Review, Acquisitions of Development Rights, Earnings Release Schedulesm and New Leaders - Research Report on Gilead, Lilly, Allergan, Incyte, and Varian Medical Systems
Editor Note: For more information about this release, please scroll to bottom.
NEW YORK, January 16, 2014
Healthy Futures Fund Finances First Community Health Center to Help Rural Washington Health System Expand to 70,000 Patient Visits Annually
Investment supported by Morgan Stanley, NDC, The Kresge Foundation and LISC
Novo Nordisk Named on the 2014 FORTUNE 100 Best Companies to Work For® List for Sixth Consecutive Year
Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease
Collaboration Brings Unique Expertise Together
THOUSAND OAKS, Calif., Jan.
BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors
NEW YORK, January 15, 2014 /PRNewswire/ --